These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 8164040)
1. Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. Reiter A; Schrappe M; Tiemann M; Parwaresch R; Zimmermann M; Yakisan E; Dopfer R; Bucsky P; Mann G; Gadner H J Clin Oncol; 1994 May; 12(5):899-908. PubMed ID: 8164040 [TBL] [Abstract][Full Text] [Related]
2. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group. Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597 [TBL] [Abstract][Full Text] [Related]
3. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Seidemann K; Tiemann M; Schrappe M; Yakisan E; Simonitsch I; Janka-Schaub G; Dörffel W; Zimmermann M; Mann G; Gadner H; Parwaresch R; Riehm H; Reiter A Blood; 2001 Jun; 97(12):3699-706. PubMed ID: 11389005 [TBL] [Abstract][Full Text] [Related]
4. [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3: An intermediate term analysis of the B-NHL/B-ALL]. Reiter A; Schrappe M; Yakisan E; Sauter S; Ebell W; Zimmermann M; Hartmann W; Kremens B; Kuhn N; Claviez A Klin Padiatr; 1994; 206(4):242-52. PubMed ID: 7967420 [TBL] [Abstract][Full Text] [Related]
5. Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group. Reiter A; Schrappe M; Ludwig WD; Lampert F; Harbott J; Henze G; Niemeyer CM; Gadner H; Müller-Weihrich S; Ritter J Blood; 1992 Nov; 80(10):2471-8. PubMed ID: 1421370 [TBL] [Abstract][Full Text] [Related]
6. Therapy of B-cell acute lymphoblastic leukaemia in childhood: the BFM experience. Reiter A Baillieres Clin Haematol; 1994 Jun; 7(2):321-37. PubMed ID: 7803904 [TBL] [Abstract][Full Text] [Related]
7. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial. Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J; J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125 [TBL] [Abstract][Full Text] [Related]
8. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica. Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699 [TBL] [Abstract][Full Text] [Related]
9. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Reiter A; Schrappe M; Tiemann M; Ludwig WD; Yakisan E; Zimmermann M; Mann G; Chott A; Ebell W; Klingebiel T; Graf N; Kremens B; Müller-Weihrich S; Plüss HJ; Zintl F; Henze G; Riehm H Blood; 1999 Nov; 94(10):3294-306. PubMed ID: 10552938 [TBL] [Abstract][Full Text] [Related]
10. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma]. Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718 [TBL] [Abstract][Full Text] [Related]
11. Results of a BFM-based protocol for the treatment of childhood B-non-Hodgkin's lymphoma and B-acute lymphoblastic leukemia in Argentina. Chantada GL; Felice MS; Zubizarreta PA; Diaz L; Gallo G; Sackmann-Muriel F Med Pediatr Oncol; 1997 May; 28(5):333-41. PubMed ID: 9121397 [TBL] [Abstract][Full Text] [Related]
12. Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group. Seidemann K; Tiemann M; Lauterbach I; Mann G; Simonitsch I; Stankewitz K; Schrappe M; Zimmermann M; Niemeyer C; Parwaresch R; Riehm H; Reiter A; J Clin Oncol; 2003 May; 21(9):1782-9. PubMed ID: 12721255 [TBL] [Abstract][Full Text] [Related]
13. Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients. Zinzani PL; Bendandi M; Martelli M; Falini B; Sabattini E; Amadori S; Gherlinzoni F; Martelli MF; Mandelli F; Tura S; Pileri SA J Clin Oncol; 1996 Mar; 14(3):955-62. PubMed ID: 8622045 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of the efficacy of CCCG-97 and BFM-90 protocols in the treatment for children with mature B-cell non-Hodgkin's lymphoma]. Meng JH; Gao YJ; Lu FJ; Zhai XW; Wang HS; Li J Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):222-7. PubMed ID: 22780979 [TBL] [Abstract][Full Text] [Related]
15. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report. Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975 [TBL] [Abstract][Full Text] [Related]
16. Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol. Sun XF; Zhen ZJ; Lui DG; Xia Y; He YJ; Wang ZH; Lin JY; Guan ZZ Eur J Haematol; 2006 Nov; 77(5):365-71. PubMed ID: 16879606 [TBL] [Abstract][Full Text] [Related]
17. [Therapeutic management of central nervous system lymphomas in a single hematological institute]. Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012 [TBL] [Abstract][Full Text] [Related]
18. Results of AIEOP LNH-97 protocol for the treatment of anaplastic large cell lymphoma of childhood. Pillon M; Gregucci F; Lombardi A; Santoro N; Piglione M; Sala A; D'Amore ES; De Santis R; Casale F; Zecca M; Mussolin L; Rosolen A; Pediatr Blood Cancer; 2012 Nov; 59(5):828-33. PubMed ID: 22389307 [TBL] [Abstract][Full Text] [Related]
19. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000. Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H; Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465 [TBL] [Abstract][Full Text] [Related]
20. [Efficacy of therapy of different variants of anaplastic large T-cell lymphomas]. Vinogradova IuE; Lutsenko IN; Kaplanskaia IB; Vorob'ev IA; Samoĭlova RS; Gorgidze LA; Ryzhikova NA; Valiev TT; Giliazitdinova EA; Dzhulakian UL; Egorova EK; Zvonkov EE; Krasil'nikova BB; Magomedova AU; Margolin OV; Mar'in DS; Kremenetskaia AM; Kravchenko SK; Vorob'ev AI Ter Arkh; 2008; 80(7):33-7. PubMed ID: 18763592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]